More about

Methotrexate

News
September 23, 2020
3 min read
Save

Pegloticase plus methotrexate bested pegloticase alone in uncontrolled gout response

Pegloticase plus methotrexate bested pegloticase alone in uncontrolled gout response

An increased proportion of patients with uncontrolled gout maintained treatment response at 6 months with concomitant methotrexate and pegloticase, compared with pegloticase alone, according to data published in The Journal of Rheumatology.

News
August 26, 2020
2 min read
Save

Subcutaneous vs. oral methotrexate safer, better-tolerated in routine practice

Subcutaneous vs. oral methotrexate safer, better-tolerated in routine practice

Subcutaneous methotrexate is safe in clinical practice, and is continued longer and better tolerated than other therapy groups, particularly oral methotrexate, according to data published in Arthritis Care & Research.

News
August 18, 2020
1 min read
Save

Patients with IBD discontinue methotrexate at higher rate than thiopurines

Patients with inflammatory bowel disease discontinued methotrexate therapy at twice the rate seen in those who used optimized thiopurine therapy, according to study results.

News
August 11, 2020
2 min read
Save

Ixekizumab outperforms adalimumab for joint, skin improvement in PsA

Ixekizumab outperforms adalimumab for joint, skin improvement in PsA

Ixekizumab demonstrated significantly greater joint and skin improvement, through week 52, than adalimumab among patients with psoriatic arthritis, according to data published in the Annals of the Rheumatic Diseases.

News
August 09, 2020
2 min read
Save

Earlier switching, aggressive treatment approaches may be best for RA

Earlier switching, aggressive treatment approaches may be best for RA

Although there is a wide array of therapies for patients with rheumatoid arthritis, the choice of when and how aggressively to employ them can sometimes conflict with established guidelines, according to a presenter.

News
August 06, 2020
3 min read
Save

2020 AAD Psoriasis Guidelines: Methotrexate Gets a Makeover

2020 AAD Psoriasis Guidelines: Methotrexate Gets a Makeover

Methotrexate is an old friend of dermatologists that we know well.

News
August 03, 2020
2 min read
Save

Upadacitinib superior to methotrexate in treating rheumatoid arthritis

Upadacitinib superior to methotrexate in treating rheumatoid arthritis

Upadacitinib monotherapy, at 15 or 30 mg daily, significantly improves clinical, radiographic and patient-reported outcomes in rheumatoid arthritis, compared with weekly methotrexate, according to data published in Arthritis & Rheumatology.

News
July 30, 2020
2 min read
Save

Methotrexate does not increase risk for rheumatoid arthritis-associated ILD

Methotrexate does not increase risk for rheumatoid arthritis-associated ILD

Methotrexate use by patients with rheumatoid arthritis was not associated with an increased risk for developing interstitial lung disease, according to a study published in European Respiratory Journal.

News
June 18, 2020
2 min read
Save

Combining etanercept, methotrexate improves psoriasis in psoriatic arthritis

Combining etanercept, methotrexate improves psoriasis in psoriatic arthritis

Etanercept monotherapy or a combination of etanercept and methotrexate had better psoriasis outcomes than methotrexate alone, according to a poster presented at the American Academy of Dermatology virtual meeting.

News
May 27, 2020
3 min read
Save

Triple therapy inferior to TNF plus methotrexate for persistence, RA disease activity outcomes

Triple therapy inferior to TNF plus methotrexate for persistence, RA disease activity outcomes

Combination therapy with TNF inhibitors plus methotrexate was significantly superior to triple therapy with methotrexate, hydroxychloroquine and sulfasalazine in patients with rheumatoid arthritis, both in terms of persistence and improved disease activity, according to data published in Arthritis Care & Research.

View more